Filippo Birocchi

17PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 18, 2026
Gene regulatory elements determine efficacy of BCMA-targeted CAR-T cell products.

|Sep 02, 2026
Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T.

|Jul 24, 2026
Genomic correlates of clinical CAR T cell activity.

|Apr 09, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.

Jooho Chung, Mounica Vallurupalli, Sarah Noel

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Dec 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms.

Maria Davern, Cole J Turner, Daryl Griffin

Pageof 3

Frequent Collaborators

15 joint publications

Marcela V Maus

12 joint publications

Mark B Leick

10 joint publications

Giulia Escobar

7 joint publications

Alexander Armstrong